Back to
JACOBS LEVY EQUITY MANAGEMENT, INC
PRPRAX
Showing 0 of 6 quarters
Position history for
JACOBS LEVY EQUITY MANAGEMENT, INC's holdings in PRAXIS PRECISION MEDICINES I
As of its Q3 2023 13F, Jacobs Levy Equity Management held 683,379 shares of PRAX (Praxis Precision Medicines), worth $1.2M. Jacobs Levy Equity Management's 13F filings listed PRAX from Q2 2023 to Q3 2023, 2 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.